Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
874 Optimizing a combination radio-immunotherapy regimen in a preclinical model of treatment-resistant, high-risk neuroblastoma
Compose a Response to This Article
Other responses
No responses have been published for this article.